Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,408 public trials 1,033 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Recruiting

A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT07218341

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • Mitchell Cancer Institute Mobile, Alabama, United States
  • Arizona Oncology Associates, P.C. - HOPE Tucson, Arizona, United States
  • Cancer Specialists, LLC Jacksonville, Florida, United States
  • Minnesota Oncology Hematology, P.A. Coon Rapids, Minnesota, United States
View all 50 locations
View Trial Details
Recruiting

Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer

NCT07046078

Conditions
Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia, Bone Marrow Diseases, +22 more
Locations
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Recruiting

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

NCT05429632

Conditions
Adult Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • University of Alabama Hospital (UAB Hospital) Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Comprehensive Cancer Center - Duarte Duarte, California, United States
  • University of California Los Angeles (UCLA) - David Geffen School of Medicine Los Angeles, California, United States
View all 111 locations
View Trial Details
Recruiting

Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR

NCT02416388

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • CH Amiens Hôpital Sud Amiens, France
  • CHU Angers Angers, France
  • CH Victor Dupouy Argenteuil, France
  • Centre Hospitalier de la Côte Basque Bayonne, France
View all 56 locations
View Trial Details

Related conditions